June 3 (Reuters) - Antibe Therapeutics Inc ATE.V :
* ANTIBE THERAPEUTICS UNVEILS LEAD INDICATION FOR ATB-352, A POTENT, NON-ADDICTIVE ANALGESIC FOR SEVERE PAIN
* ANTIBE THERAPEUTICS INC - PLANS TO PURSUE A FAST TRACK DESIGNATION WITH FDA TO EXPEDITE DEVELOPMENT AND REGULATORY APPROVAL PROCESS FOR ATB-352